Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Oct 22;5(10):e008501.
doi: 10.1136/bmjopen-2015-008501.

Comparative effectiveness of inhaled corticosteroids for paediatric asthma: protocol for a systematic review and Bayesian network meta-analysis

Masato Takeuchi  1 , Hirotsugu Kano  2 , Kenzo Takahashi  3 , Tsutomu Iwata  4
Affiliations
Comparative Study

Comparative effectiveness of inhaled corticosteroids for paediatric asthma: protocol for a systematic review and Bayesian network meta-analysis

Masato Takeuchi et al. BMJ Open. .

Abstract

Introduction: Use of inhaled corticosteroid (ICS) is the mainstream maintenance therapy for paediatric asthma. Several forms of ICS are available, but the relative effectiveness among ICS has not been well investigated in published, randomised, controlled trials. The paucity of direct comparisons between ICS may have resulted in insufficient estimation in former systematic reviews/meta-analyses. To supplement the information on the comparative effectiveness of ICS for paediatric asthma, we plan to conduct a network meta-analysis that will enable summary of direct and indirect evidence.

Methods and analysis: We will retrieve randomised, controlled trials that examined the effectiveness of ICS for paediatric asthma from the PubMed and Cochrane Central Register of Controlled Trials. After one author scans the title and abstract for eligible studies, two authors will independently review study data and assess the quality of the study. Studies of children (≤18 years old) with chronic asthma or recurrent wheezing episodes will be included if they used ICS for ≥4 weeks. We will define a priori core outcomes and supplemental outcomes of paediatric asthma, including exacerbation, healthcare use and pulmonary function. Studies reporting a minimum of one core outcome will be entered into the systematic review. After the systematic review is performed, extracted data of relevant studies will be synthesised in the Bayesian framework using a random-effects model.

Ethics and dissemination: The results will be disseminated through peer-reviewed publications and conference presentations.

Protocol registration number: UMIN (000016724) and PROSPERO (CRD42015025889).

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Scheme for pairwise meta-analysis. In this example, the comparison of ‘B vs C’ is impractical. (b) Scheme for pairwise and network (indirect) meta-analysis. An indirect comparison of ‘B vs C’ can be estimated from knowledge of ‘A vs B’ and ‘A vs C’ trials.
Figure 2
Figure 2
Scheme for a complex network in network meta-analysis (ICS, inhaled corticosteroid).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Guilbert T, Moss HM, Lemanske RF Jr. Approach to infants and children with asthma. In; Adkinson NF Jr, Bochner BS, Busse WW et al.. eds Middleton's allergy: principles and practice. Philadelphia; Saunders, 2009:1319–44.
    1. Bianchi M, Clavenna A, Labate L et al. . Anti-asthmatic drug prescriptions to an Italian paedriatic population. Pediatr Allergy Immunol 2009;20:585–91. 10.1111/j.1399-3038.2008.00797.x - DOI - PubMed
    1. Bianchi M, Clavenna A, Bonati M. Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000–2009 period. Eur J Clin Pharmacol 2010;66:929–36. 10.1007/s00228-010-0845-y - DOI - PubMed
    1. Centers for Disease Control and Prevention. CDC vital signs: Asthma in the US 2011. http://www.cdc.gov/vitalsigns/pdf/2011–05-vitalsigns.pdf (accessed 16 Mar 2015).
    1. Hanania NA. Targeting airway inflammation in asthma: current and future therapies. Chest 2008;133:989–98. 10.1378/chest.07-0829 - DOI - PubMed

Publication types

Substances